CXI Healthcare to raise 33.57M HKD via private placement
씨엑스아이
900120
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2767
Risk-adjusted indicator based on 2767 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Operating Funds: 33,570,701.93 HKD (approx. 6.60B KRW)
- • Par Value per Share: 0.5 USD (approx. 770.75 KRW)
- • Pre-increase Shares Outstanding: 3,700,000 Shares (as of May 20, 2026, reflecting June 12, 2026 issuance)
- • Issuance Date: July 01, 2026
AI Analysis Summary
CXI Healthcare Technology Group Limited announced a private placement capital increase to raise 33,570,701.93 HKD (approximately 6.60 billion KRW) for operating funds. The par value per share is 0.5 USD (770.75 KRW). The issuance price will be determined with a 9.68% premium over the reference stock price. The company cited challenges in securing large-scale funding in the Korean market and the need for capital to enhance financial soundness and strengthen its going concern basis, despite potential share dilution for existing shareholders. The funds will support business operations, investment, and expansion for the company and its subsidiaries, including securing tea cultivation sites and marketing expenses.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.